Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep747 | Neuroendocrinology | ECE2016

Limited value of the standard 8-hour water deprivation test in the diagnostic work-up of patients with suspected diabetes insipidus

Trimpou Penelope , Olsson Daniel S. , Ragnarsson Oskar

Background: Diabetes insipidus (DI) is characterized by polyuria and consequently thirst and polydipsia. Excessive water intake can also cause polyuria, i.e. primary polydipsia. It is of utmost importance to differentiate between the two disorders since the treatment is different.Aims: To study the clinical value of the standard 8-hour as well as an extended water deprivation test in patients with polyuria and polydipsia.P...

ea0063p1011 | Interdisciplinary Endocrinology 2 | ECE2019

The prevalence of oral glucocorticoid use in doses associated with risk of tertiary adrenal insufficiency

Einarsdottir Margret J , Trimpou Penelope , Olsson Daniel S , Johannsson Gudmundur , Ragnarsson Oskar

Objective: Patients who receive ≥5 mg prednisolone per day, for more than 2–3 weeks, are at risk of developing glucocorticoid (GC) induced adrenal insufficiency (tertiary adrenal insufficiency, 3° AI). The aim of this study was to a) determine the prevalence of GC use in doses that are associated with development of 3° AI, b) assess prescription pattern of short and long-term GC treatment in adults and children, and c) investigate the indication for the GC...

ea0037gp.20.01 | Pituitary – Hypopituitarism | ECE2015

Reduced mortality due to malignant neoplasms in patients receiving long-term GH replacement therapy – a Swedish study based on more than 4000 patient-years

Olsson Daniel S , Nilsson Anna G , Trimpou Penelope , Bengtsson Bengt-AEke , Andersson Eva , Johannsson Gudmundur

Patients with hypopituitarism and untreated growth hormone (GH) deficiency have excess mortality. GH replacement therapy (GHRT) has many beneficial effects, but its impact on mortality has not been proven and there are still safety concerns regarding the potential cancer risk. We have therefore studied the mortality in non-functioning pituitary adenoma (NFPA) patients with and without GHRT. Only patients with NFPA were studied in order to eliminate the influence of the aetiolo...

ea0073aep39 | Adrenal and Cardiovascular Endocrinology | ECE2021

Increasing incidence of primary aldosteronism – yet an underdiagnosed disorder

Gkaniatsa Eleftheria , Ekerstad Eva , Gavric Emanuela , Trimpou Penelope , Olsson Daniel S. , Johannsson Gudmundur , Ragnarsson Oskar

ContextPrimary aldosteronism (PA) is the most common cause of secondary hypertension. Yet, the incidence of PA in the population has not been studied.ObjectiveTo estimate the incidence of PA in western Sweden.Design and methodsPatients who had received a diagnostic code for PA between 1987 and 2016 were identified in the Swedish National Patient Registry. Assessme...

ea0070aep605 | Pituitary and Neuroendocrinology | ECE2020

An education programme for patients with pituitary tumours and their relatives; preliminary results

Tiberg Persson Jenny , Jakobsson Sofie , Cid Käll Kristina , Kullin Lena , Olofsson Ann-Charlotte , Wittboldt Ia , Skoglund Thomas , Trimpou Penelope , Jakobsson Ung Eva , Johannsson Gudmundur

Background: Patients with pituitary tumour live with life-long consequences of their disease. The first year after pituitary surgery represents a time period of symptoms, fear of tumour recurrence, existential concerns as well as extensive medical evaluations and decisions about hormone replacement. To increase wellbeing, a person-centred care practice up to 1 year after pituitary surgery covering self-management support, accessibility and continuity has been implemented and a...